August 15, 2015 Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
July 8, 2015 Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates Offringa M, Davis JM, Turner MA, Ward R, Bax R, Maldonado S, Sinha V, McCune SK, Zajicek A, Daniel K. Benjamin J, Bucci-Rechtweg C
July 28, 2015 Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
July 27, 2015 FDA: Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment Over the Spectrum of Disease
July 14, 2015 The Predictive Safety Testing Consortium: Safety Biomarkers, Collaboration, and Qualification
June 26, 2015 Patient-Centered Research To Support The Development Of The Symptoms Of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research
June 15, 2015 Assessing the Landscape of Tools and Approaches for Novel Tuberculosis Regimen Development
December 6, 2015 Development of a Patient-Reported Outcome Instrument to Assess Complex Activities of Daily Living and Interpersonal Functioning in Persons with Mild Cognitive Impairment: The Qualitative Research Phase